Tag Archives: NASDAQ:EKSO

H.C. Wainwright Reiterates Their Buy Rating on EKSO BIONICS (EKSO)

In a report released today, Swayampakula Ramakanth from H.C. Wainwright reiterated a Buy rating on EKSO BIONICS (EKSO – Research Report), with a price target of $12.00. The company’s shares closed last Thursday at $7.36. According to TipRanks.com, Ramakanth is

Aegis Capital Thinks EKSO BIONICS’s Stock is Going to Recover

In a report issued on August 5, Nathan Weinstein from Aegis Capital maintained a Buy rating on EKSO BIONICS (EKSO – Research Report), with a price target of $2.90. The company’s shares opened today at $0.89, close to its 52-week

What Did This CEO Just Do with Personal Shares of EKSO BIONICS (NASDAQ: EKSO)?

Today, the CEO of EKSO BIONICS (EKSO – Research Report), Jack Peurach, sold shares of EKSO for $43.07K. In addition to Jack Peurach, 2 other EKSO executives reported Sell trades in the last month. See today’s analyst top recommended stocks

The President of EKSO BIONICS (NASDAQ: EKSO) is Selling Shares

Today, the President of EKSO BIONICS (NASDAQ: EKSO), Russ Angold, sold shares of EKSO for $175.5K. Following Russ Angold’s last EKSO Sell transaction on September 05, 2017, the stock climbed by 1.7%. Based on EKSO BIONICS’s latest earnings report for

The CFO of EKSO BIONICS (NASDAQ: EKSO) is Buying Shares

Today, the CFO of EKSO BIONICS (NASDAQ: EKSO), Max Scheder-Bieschin, bought shares of EKSO for $3,990. Following this transaction Max Scheder-Bieschin’s holding in the company was increased by 11.34% to a total of $253K. In addition to Max Scheder-Bieschin, one

The President & Chief Com. Officer of EKSO BIONICS (NASDAQ: EKSO) is Buying Shares

Today, the President & Chief Com. Officer of EKSO BIONICS (NASDAQ: EKSO), Tom Looby, bought shares of EKSO for $3,980. This recent transaction increases Tom Looby’s holding in the company by 166.67% to a total of $16.4K. The company has